Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lubragel is a sterile, water-soluble, CE-marked Class III medical device designed for use as a lubricating gel during medical procedures such as urethral catheterization, endoscopy, and cystoscopy. It is formulated with lidocaine hydrochloride, which acts as a local anesthetic to minimize pain during the insertion of medical devices, with an onset of action within 3-5 minutes and a duration of 20-30 minutes. In addition to its primary lubricating function, Lubragel possesses antiseptic properties to reduce the risk of iatrogenic infection and helps prevent trauma to the urethral, rectal, or colonic mucosa. It is typically supplied in pre-filled, sterile disposable syringes (6ml, 11ml, 12.5ml) for clinical convenience.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lubragel.